Ignite Creation Date:
2025-12-24 @ 3:51 PM
Ignite Modification Date:
2025-12-26 @ 9:00 AM
Study NCT ID:
NCT04553692
Status:
TERMINATED
Last Update Posted:
2025-03-28
First Post:
2020-09-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers
Sponsor:
IGM Biosciences, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-23
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-01-20
Completion Date Type:
ACTUAL
First Submit Date:
2020-09-04
First Submit QC Date:
None
Study First Post Date:
2020-09-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-25
Last Update Post Date:
2025-03-28
Last Update Post Date Type:
ACTUAL